To test the relative efficacy of clopidogrel (75 mg once daily ) and aspirin (325 mg once daily) for prevention of stroke, myocardial infarction or vascular death.
- Aspirin (stroke prevention) Drug
Intervention Desc: Antiplatelet agent; inhibits thromboxane A2
- Clopidogrel (Plavix®)Drug
Other Names: Plavix, Clodelib, Clovelen Intervention Desc: Antiplatelet agent
Randomized, double-blind, international trial of 19,185 patients at 384 centers in 16 countries.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Ischemic stroke, myocardial infarction, or vascular death during 1-3 year follow-up period.|